Omeprazole inhibits natural killer cell functions (Q42514828)

1 November 2017

Omeprazole inhibits natural killer cell functions (English)

1 reference

1 November 2017

1 reference

Huseyin Alkim

1

1 reference

1 November 2017

Selahattin Unal

series ordinal

2

1 reference

1 November 2017

Hamza Okur

series ordinal

3

1 reference

1 November 2017

Turgut Imir

series ordinal

4

1 reference

1 November 2017

28 June 2007

1 reference

Digestive Diseases and Sciences

1 November 2017

1 reference

1 November 2017

53

1 reference

1 November 2017

2

1 reference

1 November 2017

347-351

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-007-9869-2

1 November 2017

0 references

cites work

Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extracts of Helicobacter pylori

1 reference

12 December 2020

Proton atpases: structure and mechanism

1 reference

12 December 2020

Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils

1 reference

12 December 2020

Recycling and target binding capacity of human natural killer cells

1 reference

12 December 2020

Evidence of a dynamic role of the target cell membrane during the early stages of the natural killer cell lethal hit

1 reference

12 December 2020

A view of acidic intracellular compartments

1 reference

12 December 2020

1 reference

12 December 2020

Omeprazole for duodenal ulceration in Crohn's disease

1 reference

12 December 2020

Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders

1 reference

12 December 2020

The gastric H+,K+-ATPase: the site of action of omeprazole

1 reference

12 December 2020

A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions

1 reference

12 December 2020

Inhibition of human natural killer activity by lysosomotropic agents.

1 reference

12 December 2020

Activity inhibition of cytolytic lymphocytes by omeprazole

1 reference

12 December 2020

The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation

1 reference

12 December 2020

Acidification of the endocytic and exocytic pathways

1 reference

12 December 2020

Omeprazole attenuates oxygen-derived free radical production from human neutrophils

1 reference

12 December 2020

The relative resistance of lymphokine activated killer cells to suppression by prostaglandins and glucocorticoids

1 reference

12 December 2020

The effect of omeprazole on human natural killer cell activity

1 reference

12 December 2020

The mechanisms involved in the activation of human natural killer cells by staphylococcal enterotoxin B

1 reference

12 December 2020

Omeprazole and neutrophil function

1 reference

12 December 2020

Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome

1 reference

12 December 2020

The mechanism of action of the gastric acid secretion inhibitor omeprazole

1 reference

12 December 2020

Lansoprazole Inhibits Oxygen-Derived Free Radical Production from Neutrophils Activated by Helicobacter pylori

1 reference

12 December 2020

Specific labelling of gastric H+,K+-ATPase by omeprazole

1 reference

12 December 2020

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

1 reference

12 December 2020

Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

1 reference

12 December 2020

Effect of lansoprazole on human leukocyte function

1 reference

12 December 2020

Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245

1 reference

12 December 2020

10.1007/S10620-007-9869-2

Identifiers

DOI

1 reference

1 November 2017

1 reference